The Readout Loud
STAT
Add to My Podcasts
Episodes
About
Reviews
Promote
Episode 69: The future of AbbVieGan, the dogma of amyloid, & some questionable biotech marketing
25 minutes
Posted Jun 27, 2019 at 8:50 pm.
0:00
25:31
Add to My Queue
Download
MP3
Share
episode
Share at current time
Show notes
Can Botox make Big Pharma attractive? What qualifies as a "cabal"? And will the CRISPR patent fight outlive us all?
Previous
Episode 68: A controversial desire drug, courtroom genealogy, & the quest for longer life
Next
Episode 70: A whirlwind week in Washington, Sean Parker's mansion, & remembering a voice in biotech
← See all 424 episodes of The Readout Loud
